Passage Bio Inc. (NASDAQ: PASG)
$0.5310
-0.0050 ( -1.67% ) 70.9K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.5310
Previous close
$0.5360
Volume
70.9K
Market cap
$32.89M
Day range
$0.5230 - $0.5700
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Sep 06, 2024 |
| 3 | Insider transactions | 1 | Aug 09, 2024 |
| 10-q | Quarterly Reports | 64 | Aug 08, 2024 |
| 8-k | 8K-related | 45 | Aug 08, 2024 |
| 8-k | 8K-related | 13 | Aug 02, 2024 |
| 8-k | 8K-related | 15 | Aug 01, 2024 |
| 8-k | 8K-related | 15 | Jul 16, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |
| 4 | Insider transactions | 1 | May 23, 2024 |